Nolan J P
Gastroenterology. 1975 Dec;69(6):1346-56.
Evidence is present that a common pathway for hepatic injury by a variety of agents may result from impairment of the liver's ability to detoxify bacterial endotoxins from the gastrointestinal tract. Many factors may structurally, metabolically, or hormonally alter the normal liver's ability to render innocuous the small amounts of lipopolysaccharide ordinarily presented to it. This impairment may accentuate existing hepatic damage by allowing toxic levels of endotoxin to develop in the liver tissue, and by allowing endotoxin entry into the systemic circulation, may also lead to extrahepatic effects. Studies are cited that: (1) support a role for intraintestinal endotoxin in the development of experimental cirrhosis. (2) demonstrate how liver injury alters endotoxin detoxification, (3) examine the role of intestinal production and absorption of bacterial lipopolysaccharides in liver disease, and (4) point to a role for endotoxemia in extrahepatic manifestations of liver injury as well. Studies are also reviewed that suggest possible mechanisms for modifying endotoxicity in hepatic damage.
有证据表明,多种因素导致肝损伤的共同途径可能是肝脏对胃肠道细菌内毒素解毒能力受损。许多因素可能在结构、代谢或激素方面改变正常肝脏将通常进入其中的少量脂多糖无害化的能力。这种损害可能会因肝脏组织中内毒素水平升高而加重现有的肝损伤,并且由于内毒素进入体循环,还可能导致肝外效应。引用的研究表明:(1)支持肠内毒素在实验性肝硬化发展中的作用;(2)证明肝损伤如何改变内毒素解毒;(3)研究肠道细菌脂多糖的产生和吸收在肝病中的作用;(4)指出内毒素血症在肝损伤肝外表现中的作用。还综述了一些研究,这些研究提出了改变肝损伤中内毒素毒性的可能机制。